Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Mayer, Robert
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Robert James Mayer, M.D.
Title
Stephen B. Kay Family Professor of Medicine
Institution
Dana-Farber Cancer Institute
Department
Medicine
Address
Dana Farber Cancer Institute
D 1602
44 Binney St
Boston MA 02115
Phone
617/632-3474
Fax
617/632-2260
vCard
Download vCard
(
login for email
)
Other Positions
Title
Faculty Associate Dean for Admissions
Institution
Harvard Medical School
Department
PME
research activities and funding
|
selected publications
|
Research
research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can
login
to make corrections and additions.
Most Recent
|
List All
K12CA001730
(MAYER, ROBERT J)
Sep 17, 1992 - Aug 31, 1997
NIH
CLINICAL ONCOLOGY RESEARCH CAREER DEVELOPMENT PROGRAM
Role: Principal Investigator
T32CA009172
(DECAPRIO, JAMES A)
Jul 1, 1978 - Jun 30, 2016
NIH
Graduate Training in Cancer Research
Role: Principal Investigator
M01RR000044
(GUZICK, DAVID S)
Oct 1, 1974 - Sep 29, 2006
NIH/NCRR
General Clinical Research Center
Role: Co-Principal Investigator
Bibliographic
selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can
login
to make corrections and additions.
Newest
|
Oldest
|
Most Cited
|
Most Discussed
|
Timeline
|
Field Summary
|
Plain Text
PMC Citations
indicate the number of times the publication was cited by articles in PubMed Central, and the
Altmetric
score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.)
Fields
are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication.
Translation
tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
Yuan C
, Sato K, Hollis BW, Zhang S, Niedzwiecki D, Ou FS, Chang IW, O'Neil BH, Innocenti F, Lenz HJ, Blanke CD, Goldberg RM, Venook AP,
Mayer RJ
, Fuchs CS,
Meyerhardt JA
,
Ng K
. Plasma 25-Hydroxyvitamin D Levels and Survival in Patients with Advanced or Metastatic Colorectal Cancer: Findings from CALGB/SWOG 80405 (Alliance). Clin Cancer Res. 2019 12 15; 25(24):7497-7505.
PMID:
31548349
.
Citations:
8
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Guercio BJ, Zhang S, Ou FS, Venook AP, Niedzwiecki D, Lenz HJ, Innocenti F, O'Neil BH, Shaw JE, Polite BN, Hochster HS, Atkins JN, Goldberg RM, Sato K,
Ng K
, Van Blarigan E,
Mayer RJ
, Blanke CD, O'Reilly EM, Fuchs CS,
Meyerhardt JA
. Associations of Physical Activity With Survival and Progression in Metastatic Colorectal Cancer: Results From Cancer and Leukemia Group B (Alliance)/SWOG 80405. J Clin Oncol. 2019 10 10; 37(29):2620-2631.
PMID:
31408415
.
Citations:
7
Fields:
Neo
Neoplasms
Translation:
Humans
Triunfo S,
Mayer R
, Danza M, Lanzone A. Reasons of reduced physical activity in preconception and pregnancy. Minerva Med. 2019 Jul 09.
PMID:
31295984
.
Citations:
Fields:
Med
Medicine (General)
Kosumi K, Hamada T, Zhang S, Liu L, da Silva A, Koh H, Twombly TS, Mima K, Morikawa T, Song M,
Nowak JA
, Nishihara R, Saltz LB, Niedzwiecki D, Ou FS, Zemla T,
Mayer RJ
, Baba H,
Ng K
,
Giannakis M
, Zhang X,
Wu K
,
Giovannucci EL
,
Chan AT
, Fuchs CS,
Meyerhardt JA
,
Ogino S
. Prognostic association of PTGS2 (COX-2) over-expression according to BRAF mutation status in colorectal cancer: Results from two prospective cohorts and CALGB 89803 (Alliance) trial. Eur J Cancer. 2019 04; 111:82-93.
PMID:
30826660
.
Citations:
6
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
Morales-Oyarvide V
, Yuan C,
Babic A
, Zhang S, Niedzwiecki D, Brand-Miller JC, Sampson-Kent L, Ye X, Li Y, Saltz LB,
Mayer RJ
, Mowat RB, Whittom R, Hantel A, Benson A, Atienza D, Messino M, Kindler H, Venook A,
Ogino S
,
Wu K
, Willett WC,
Giovannucci EL
,
Wolpin BM
,
Meyerhardt JA
, Fuchs CS,
Ng K
. Dietary Insulin Load and Cancer Recurrence and Survival in Patients With Stage III Colon Cancer: Findings From CALGB 89803 (Alliance). J Natl Cancer Inst. 2019 02 01; 111(2):170-179.
PMID:
30726946
.
Citations:
5
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Mayer RJ
, Hochster HS, Cohen SJ, Winkler R, Makris L, Grothey A. Safety of trifluridine/tipiracil in an open-label expanded-access program in elderly and younger patients with metastatic colorectal cancer. Cancer Chemother Pharmacol. 2018 12; 82(6):961-969.
PMID:
30350179
.
Citations:
5
Fields:
Ant
Antineoplastic Agents
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Provenzale D, Gupta S, Ahnen DJ, Markowitz AJ,
Chung DC
,
Mayer RJ
, Regenbogen SE, Blanco AM, Bray T, Cooper G, Early DS, Ford JM, Giardiello FM, Grady W, Hall MJ, Halverson AL, Hamilton SR, Hampel H, Klapman JB, Larson DW, Lazenby AJ, Llor X, Lynch PM, Mikkelson J, Ness RM, Slavin TP, Sugandha S, Weiss JM, Dwyer MA, Ogba N. NCCN Guidelines Insights: Colorectal Cancer Screening, Version 1.2018. J Natl Compr Canc Netw. 2018 08; 16(8):939-949.
PMID:
30099370
.
Citations:
31
Fields:
Neo
Neoplasms
Translation:
Humans
PH
Public Health
Guercio BJ, Zhang S, Niedzwiecki D, Li Y,
Babic A
,
Morales-Oyarvide V
, Saltz LB,
Mayer RJ
, Mowat RB, Whittom R, Hantel A, Benson A, Atienza D, Messino M, Kindler H, Venook A,
Ogino S
, Zoltick ES,
Stampfer M
,
Ng K
,
Wu K
,
Willett WC
,
Giovannucci EL
,
Meyerhardt JA
, Fuchs CS. Associations of artificially sweetened beverage intake with disease recurrence and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance). PLoS One. 2018; 13(7):e0199244.
PMID:
30024889
.
Citations:
2
Fields:
Med
Medicine (General)
Sci
Science
Translation:
Humans
Aguirre AJ
,
Nowak JA
, Camarda ND, Moffitt RA,
Ghazani AA
, Hazar-Rethinam M,
Raghavan S
, Kim J, Brais LK, Ragon D, Welch MW, Reilly E, McCabe D, Marini L, Anderka K, Helvie K, Oliver N,
Babic A
, Da Silva A, Nadres B, Van Seventer EE, Shahzade HA, St Pierre JP,
Burke KP
,
Clancy T
,
Cleary JM
,
Doyle LA
,
Jajoo K
,
McCleary NJ
,
Meyerhardt JA
,
Murphy JE
,
Ng K
,
Patel AK
,
Perez K
,
Rosenthal MH
,
Rubinson DA
,
Ryou M
,
Shapiro GI
,
Sicinska E
,
Silverman SG
, Nagy RJ, Lanman RB, Knoerzer D, Welsch DJ,
Yurgelun MB
, Fuchs CS, Garraway LA,
Getz G
, Hornick JL,
Johnson BE
, Kulke MH,
Mayer RJ
, Miller JW,
Shyn PB
, Tuveson DA,
Wagle N
, Yeh JJ,
Hahn WC
,
Corcoran RB
,
Carter SL
,
Wolpin BM
. Real-time Genomic Characterization of Advanced Pancreatic Cancer to Enable Precision Medicine. Cancer Discov. 2018 09; 8(9):1096-1111.
PMID:
29903880
.
Citations:
46
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
Brown JC, Zhang S, Niedzwiecki D, Saltz LB,
Mayer RJ
, Mowat RB, Whittom R, Hantel A, Benson A, Atienza D, Messino M, Kindler H, Venook A,
Ogino S
, Li Y, Zhang X,
Ng K
, Willett WC,
Giovannucci EL
, Fuchs CS,
Meyerhardt JA
. Grain Intake and Clinical Outcome in Stage III Colon Cancer: Results From CALGB 89803 (Alliance). JNCI Cancer Spectr. 2018 Feb; 2(2):pky017.
PMID:
29877501
.
Citations:
3
Fadelu T
, Zhang S, Niedzwiecki D, Ye X, Saltz LB,
Mayer RJ
, Mowat RB, Whittom R, Hantel A, Benson AB, Atienza DM, Messino M, Kindler HL, Venook A,
Ogino S
,
Ng K
,
Wu K
,
Willett W
,
Giovannucci E
,
Meyerhardt J
, Bao Y, Fuchs CS. Nut Consumption and Survival in Patients With Stage III Colon Cancer: Results From CALGB 89803 (Alliance). J Clin Oncol. 2018 04 10; 36(11):1112-1120.
PMID:
29489429
.
Citations:
14
Fields:
Neo
Neoplasms
Translation:
Humans
PH
Public Health
Gupta S, Provenzale D, Regenbogen SE, Hampel H, Slavin TP, Hall MJ, Llor X,
Chung DC
, Ahnen DJ, Bray T, Cooper G, Early DS, Ford JM, Giardiello FM, Grady W, Halverson AL, Hamilton SR, Klapman JB, Larson DW, Lazenby AJ, Lynch PM, Markowitz AJ,
Mayer RJ
, Ness RM, Samadder NJ, Shike M, Sugandha S, Weiss JM, Dwyer MA, Ogba N. NCCN Guidelines Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 3.2017. J Natl Compr Canc Netw. 2017 12; 15(12):1465-1475.
PMID:
29223984
.
Citations:
31
Fields:
Neo
Neoplasms
Translation:
Humans
Fuchs CS, Niedzwiecki D,
Mamon HJ
, Tepper JE, Ye X, Swanson RS,
Enzinger PC
, Haller DG, Dragovich T, Alberts SR, Bjarnason GA, Willett CG, Gunderson LL, Goldberg RM, Venook AP, Ilson D, O'Reilly E, Ciombor K, Berg DJ,
Meyerhardt J
,
Mayer RJ
. Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance). J Clin Oncol. 2017 Nov 10; 35(32):3671-3677.
PMID:
28976791
.
Citations:
17
Fields:
Neo
Neoplasms
Translation:
Humans
Fuchs MA, Yuan C, Sato K, Niedzwiecki D, Ye X, Saltz LB,
Mayer RJ
, Mowat RB, Whittom R, Hantel A, Benson A, Atienza D, Messino M, Kindler H, Venook A, Innocenti F, Warren RS,
Bertagnolli MM
,
Ogino S
,
Giovannucci EL
, Horvath E,
Meyerhardt JA
, Ng K. Predicted vitamin D status and colon cancer recurrence and mortality in CALGB 89803 (Alliance). Ann Oncol. 2017 Jun 01; 28(6):1359-1367.
PMID:
28327908
.
Citations:
5
Fields:
Neo
Neoplasms
Translation:
Humans
Kastrinos F,
Uno H
,
Ukaegbu C
, Alvero C, McFarland A,
Yurgelun MB
, Kulke MH,
Schrag D
,
Meyerhardt JA
, Fuchs CS,
Mayer RJ
,
Ng K
, Steyerberg EW,
Syngal S
. Development and Validation of the PREMM5 Model for Comprehensive Risk Assessment of Lynch Syndrome. J Clin Oncol. 2017 Jul 01; 35(19):2165-2172.
PMID:
28489507
.
Citations:
30
Fields:
Neo
Neoplasms
Translation:
Humans
Yurgelun MB
, Kulke MH, Fuchs CS, Allen BA,
Uno H
,
Hornick JL
,
Ukaegbu CI
, Brais LK, McNamara PG,
Mayer RJ
,
Schrag D
,
Meyerhardt JA
,
Ng K
, Kidd J, Singh N, Hartman AR, Wenstrup RJ,
Syngal S
. Cancer Susceptibility Gene Mutations in Individuals With Colorectal Cancer. J Clin Oncol. 2017 Apr 01; 35(10):1086-1095.
PMID:
28135145
.
Citations:
79
Fields:
Neo
Neoplasms
Translation:
Humans
Niedzwiecki D, Frankel WL, Venook AP, Ye X, Friedman PN, Goldberg RM,
Mayer RJ
, Colacchio TA, Mulligan JM, Davison TS, O'Brien E, Kerr P, Johnston PG, Kennedy RD, Harkin DP, Schilsky RL,
Bertagnolli MM
, Warren RS, Innocenti F. Reply to L. Casadaban et al. J Clin Oncol. 2017 04 20; 35(12):1373-1374.
PMID:
28113023
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
Niedzwiecki D, Frankel WL, Venook AP, Ye X, Friedman PN, Goldberg RM,
Mayer RJ
, Colacchio TA, Mulligan JM, Davison TS, O'Brien E, Kerr P, Johnston PG, Kennedy RD, Harkin DP, Schilsky RL,
Bertagnolli MM
, Warren RS, Innocenti F. Association Between Results of a Gene Expression Signature Assay and Recurrence-Free Interval in Patients With Stage II Colon Cancer in Cancer and Leukemia Group B 9581 (Alliance). J Clin Oncol. 2016 09 01; 34(25):3047-53.
PMID:
27432924
.
Citations:
7
Fields:
Neo
Neoplasms
Translation:
Humans
Enzinger PC
, Burtness BA, Niedzwiecki D, Ye X,
Douglas K
, Ilson DH, Villaflor VM, Cohen SJ,
Mayer RJ
, Venook A, Benson AB, Goldberg RM. CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers. J Clin Oncol. 2016 08 10; 34(23):2736-42.
PMID:
27382098
.
Citations:
27
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Sloane D
, Govindarajulu U, Harrow-Mortelliti J, Barry W, Hsu FI, Hong D,
Laidlaw T
, Palis R, Legere H, Bunyavanich S, Breslow R,
Wesemann D
,
Barrett N
,
Brennan P
, Chong HJ, Liu A, Fernandez J, Fanning L, Kyin T, Cahill K,
Bankova L
, Lynch A, Berlin S,
Campos S
, Fuchs C,
Mayer R
,
Matulonis U
,
Castells M
. Safety, Costs, and Efficacy of Rapid Drug Desensitizations to Chemotherapy and Monoclonal Antibodies. J Allergy Clin Immunol Pract. 2016 May-Jun; 4(3):497-504.
PMID:
26895621
.
Citations:
18
Fields:
All
Allergy and Immunology
Translation:
Humans
Guercio BJ, Sato K, Niedzwiecki D, Ye X, Saltz LB,
Mayer RJ
, Mowat RB, Whittom R, Hantel A, Benson A, Atienza D, Messino M, Kindler H, Venook A,
Hu FB
,
Ogino S
,
Wu K
,
Willett WC
,
Giovannucci EL
,
Meyerhardt JA
, Fuchs CS. Coffee Intake, Recurrence, and Mortality in Stage III Colon Cancer: Results From CALGB 89803 (Alliance). J Clin Oncol. 2015 Nov 01; 33(31):3598-607.
PMID:
26282659
.
Citations:
13
Fields:
Neo
Neoplasms
Translation:
Humans
Provenzale D, Jasperson K, Ahnen DJ, Aslanian H, Bray T, Cannon JA, David DS, Early DS, Erwin D, Ford JM, Giardiello FM, Gupta S, Halverson AL, Hamilton SR, Hampel H, Ismail MK, Klapman JB, Larson DW, Lazenby AJ, Lynch PM,
Mayer RJ
, Ness RM, Rao MS, Regenbogen SE, Shike M, Steinbach G, Weinberg D, Dwyer MA, Freedman-Cass DA, Darlow S. Colorectal Cancer Screening, Version 1.2015. J Natl Compr Canc Netw. 2015 Aug; 13(8):959-68; quiz 968.
PMID:
26285241
.
Citations:
25
Fields:
Neo
Neoplasms
Translation:
Humans
Mayer RJ
, Van Cutsem E, Falcone A, Yoshino T, Garcia-Carbonero R, Mizunuma N, Yamazaki K, Shimada Y, Tabernero J, Komatsu Y, Sobrero A, Boucher E, Peeters M, Tran B, Lenz HJ, Zaniboni A, Hochster H,
Cleary JM
, Prenen H, Benedetti F, Mizuguchi H, Makris L, Ito M, Ohtsu A. Randomized trial of TAS-102 for refractory metastatic colorectal cancer. N Engl J Med. 2015 May 14; 372(20):1909-19.
PMID:
25970050
.
Citations:
247
Fields:
Med
Medicine (General)
Translation:
Humans
CT
Clinical Trials
Bohanes P, Rankin CJ, Blanke CD, Winder T, Ulrich CM, Smalley SR, Rich TA, Martensen JA, Benson AB,
Mayer RJ
, Cripps CM, Danenberg K, Makar KW, Zhang W, Benedetti JK, Lenz HJ. Pharmacogenetic Analysis of INT 0144 Trial: Association of Polymorphisms with Survival and Toxicity in Rectal Cancer Patients Treated with 5-FU and Radiation. Clin Cancer Res. 2015 Apr 01; 21(7):1583-90.
PMID:
25589620
.
Citations:
6
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Ng K
,
Meyerhardt JA
,
Chan AT
, Sato K,
Chan JA
, Niedzwiecki D, Saltz LB,
Mayer RJ
, Benson AB, Schaefer PL, Whittom R, Hantel A, Goldberg RM, Venook AP,
Ogino S
,
Giovannucci EL
, Fuchs CS. Aspirin and COX-2 inhibitor use in patients with stage III colon cancer. J Natl Cancer Inst. 2015 Jan; 107(1):345.
PMID:
25432409
.
Citations:
45
Fields:
Neo
Neoplasms
Translation:
Humans
Kageyama S, Sou YS, Uemura T, Kametaka S, Saito T, Ishimura R, Kouno T, Bedford L,
Mayer RJ
, Lee MS, Yamamoto M, Waguri S, Tanaka K, Komatsu M. Proteasome dysfunction activates autophagy and the Keap1-Nrf2 pathway. J Biol Chem. 2014 Sep 05; 289(36):24944-55.
PMID:
25049227
.
Citations:
44
Fields:
Bio
Biochemistry
Translation:
Animals
Cells
Fuchs MA, Sato K, Niedzwiecki D, Ye X, Saltz LB,
Mayer RJ
, Mowat RB, Whittom R, Hantel A, Benson A, Atienza D, Messino M, Kindler H, Venook A,
Ogino S
,
Wu K
,
Willett WC
,
Giovannucci EL
,
Meyerhardt JA
. Sugar-sweetened beverage intake and cancer recurrence and survival in CALGB 89803 (Alliance). PLoS One. 2014; 9(6):e99816.
PMID:
24937507
.
Citations:
18
Fields:
Med
Medicine (General)
Sci
Science
Translation:
Humans
Mayer RJ
, Venook AP, Schilsky RL. Progress against GI cancer during the American Society of Clinical Oncology's first 50 years. J Clin Oncol. 2014 May 20; 32(15):1521-30.
PMID:
24752046
.
Citations:
19
Fields:
Neo
Neoplasms
Translation:
Humans
Burt RW, Cannon JA, David DS, Early DS, Ford JM, Giardiello FM, Halverson AL, Hamilton SR, Hampel H, Ismail MK, Jasperson K, Klapman JB, Lazenby AJ, Lynch PM,
Mayer RJ
, Ness RM, Provenzale D, Rao MS, Shike M, Steinbach G, Terdiman JP, Weinberg D, Dwyer M, Freedman-Cass D. Colorectal cancer screening. J Natl Compr Canc Netw. 2013 Dec 01; 11(12):1538-75.
PMID:
24335688
.
Citations:
23
Fields:
Neo
Neoplasms
Translation:
Humans
Ogino S
, Liao X, Imamura Y, Yamauchi M,
McCleary NJ
,
Ng K
, Niedzwiecki D, Saltz LB,
Mayer RJ
, Whittom R, Hantel A, Benson AB, Mowat RB,
Spiegelman D
, Goldberg RM,
Bertagnolli MM
,
Meyerhardt JA
, Fuchs CS. Predictive and prognostic analysis of PIK3CA mutation in stage III colon cancer intergroup trial. J Natl Cancer Inst. 2013 Dec 04; 105(23):1789-98.
PMID:
24231454
.
Citations:
22
Fields:
Neo
Neoplasms
Translation:
Humans
Jeon J, Sato K, Niedzwiecki D, Ye X, Saltz LB,
Mayer RJ
, Mowat RB, Whittom R, Hantel A, Benson A, Wigler DS, Atienza D, Messino M, Kindler H, Venook A, Fuchs CS,
Meyerhardt JA
. Impact of physical activity after cancer diagnosis on survival in patients with recurrent colon cancer: Findings from CALGB 89803/Alliance. Clin Colorectal Cancer. 2013 Dec; 12(4):233-8.
PMID:
24035029
.
Citations:
12
Fields:
Gas
Gastroenterology
Neo
Neoplasms
Translation:
Humans
Gunderson LL, Moughan J, Ajani JA, Pedersen JE, Winter KA, Benson AB, Thomas CR,
Mayer RJ
, Haddock MG, Rich TA, Willett CG. Anal carcinoma: impact of TN category of disease on survival, disease relapse, and colostomy failure in US Gastrointestinal Intergroup RTOG 98-11 phase 3 trial. Int J Radiat Oncol Biol Phys. 2013 Nov 15; 87(4):638-45.
PMID:
24035327
.
Citations:
23
Fields:
Neo
Neoplasms
Rad
Radiology
Rad
Radiotherapy
Translation:
Humans
CT
Clinical Trials
Warren RS, Atreya CE, Niedzwiecki D, Weinberg VK, Donner DB,
Mayer RJ
, Goldberg RM, Compton CC, Zuraek MB, Ye C, Saltz LB,
Bertagnolli MM
. Association of TP53 mutational status and gender with survival after adjuvant treatment for stage III colon cancer: results of CALGB 89803. Clin Cancer Res. 2013 Oct 15; 19(20):5777-87.
PMID:
23983256
.
Citations:
18
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
Mayer RJ
. Reply to A. Grothey et al and R.S. Midgley et al. J Clin Oncol. 2013 Apr 20; 31(12):1612-3.
PMID:
23734371
.
Citations:
Fields:
Neo
Neoplasms
Translation:
Humans
Chan JA
,
Mayer RJ
, Jackson N, Malinowski P, Regan E, Kulke MH. Phase I study of sorafenib in combination with everolimus (RAD001) in patients with advanced neuroendocrine tumors. Cancer Chemother Pharmacol. 2013 May; 71(5):1241-6.
PMID:
23475104
.
Citations:
17
Fields:
Ant
Antineoplastic Agents
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Gunderson LL, Winter KA, Ajani JA, Pedersen JE, Moughan J, Benson AB, Thomas CR,
Mayer RJ
, Haddock MG, Rich TA, Willett CG. Long-term update of US GI intergroup RTOG 98-11 phase III trial for anal carcinoma: survival, relapse, and colostomy failure with concurrent chemoradiation involving fluorouracil/mitomycin versus fluorouracil/cisplatin. J Clin Oncol. 2012 Dec 10; 30(35):4344-51.
PMID:
23150707
.
Citations:
113
Fields:
Neo
Neoplasms
Translation:
Humans
CT
Clinical Trials
Meyerhardt JA
, Sato K, Niedzwiecki D, Ye C, Saltz LB,
Mayer RJ
, Mowat RB, Whittom R, Hantel A, Benson A, Wigler DS, Venook A, Fuchs CS. Dietary glycemic load and cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803. J Natl Cancer Inst. 2012 Nov 21; 104(22):1702-11.
PMID:
23136358
.
Citations:
60
Fields:
Neo
Neoplasms
Translation:
Humans
PH
Public Health
Dillmon M, Goldberg JM, Ramalingam SS,
Mayer RJ
, Loehrer P, Van Poznak C. Clinical practice guidelines for cancer care: utilization and expectations of the practicing oncologist. J Oncol Pract. 2012 Nov; 8(6):350-3, 2 p following 353.
PMID:
23598844
.
Citations:
2
Fields:
Neo
Neoplasms
Translation:
Humans
Mayer RJ
. Oxaliplatin as part of adjuvant therapy for colon cancer: more complicated than once thought. J Clin Oncol. 2012 Sep 20; 30(27):3325-7.
PMID:
22915653
.
Citations:
5
Fields:
Neo
Neoplasms
Translation:
Humans
Leape LL
, Shore MF,
Dienstag JL
,
Mayer RJ
,
Edgman-Levitan S
,
Meyer GS
,
Healy GB
. Perspective: a culture of respect, part 1: the nature and causes of disrespectful behavior by physicians. Acad Med. 2012 Jul; 87(7):845-52.
PMID:
22622217
.
Citations:
53
Fields:
Edu
Education
Translation:
Humans
Leape LL
, Shore MF,
Dienstag JL
,
Mayer RJ
,
Edgman-Levitan S
,
Meyer GS
,
Healy GB
. Perspective: a culture of respect, part 2: creating a culture of respect. Acad Med. 2012 Jul; 87(7):853-8.
PMID:
22622219
.
Citations:
33
Fields:
Edu
Education
Translation:
Humans
Katz L, Tripp DA, Nickel JC,
Mayer R
, Reimann M, van Ophoven A. Disability in women suffering from interstitial cystitis/bladder pain syndrome. BJU Int. 2013 Jan; 111(1):114-21.
PMID:
22578191
.
Citations:
6
Fields:
Uro
Urology
Translation:
Humans
Shinagare AB
, Ramaiya NH, Bellizzi AM,
Mayer RJ
. Locally advanced anaplastic pancreatic adenocarcinoma with initial response to FOLFIRINOX and rapid progression after five months. Pancreatology. 2012 Jan-Feb; 12(1):35-8.
PMID:
22487471
.
Citations:
2
Fields:
End
Endocrinology
Gas
Gastroenterology
Translation:
Humans
Ogino S
, Shima K,
Meyerhardt JA
,
McCleary NJ
,
Ng K
, Hollis D, Saltz LB,
Mayer RJ
, Schaefer P, Whittom R, Hantel A, Benson AB,
Spiegelman D
, Goldberg RM,
Bertagnolli MM
, Fuchs CS. Predictive and prognostic roles of BRAF mutation in stage III colon cancer: results from intergroup trial CALGB 89803. Clin Cancer Res. 2012 Feb 01; 18(3):890-900.
PMID:
22147942
.
Citations:
116
Fields:
Neo
Neoplasms
Translation:
Humans
Ng K
,
Ogino S
,
Meyerhardt JA
,
Chan JA
,
Chan AT
, Niedzwiecki D, Hollis D, Saltz LB,
Mayer RJ
, Benson AB, Schaefer PL, Whittom R, Hantel A, Goldberg RM,
Bertagnolli MM
, Venook AP, Fuchs CS. Relationship between statin use and colon cancer recurrence and survival: results from CALGB 89803. J Natl Cancer Inst. 2011 Oct 19; 103(20):1540-51.
PMID:
21849660
.
Citations:
21
Fields:
Neo
Neoplasms
Translation:
Humans
Bertagnolli MM
,
Redston M
, Compton CC, Niedzwiecki D,
Mayer RJ
, Goldberg RM, Colacchio TA, Saltz LB, Warren RS. Microsatellite instability and loss of heterozygosity at chromosomal location 18q: prospective evaluation of biomarkers for stages II and III colon cancer--a study of CALGB 9581 and 89803. J Clin Oncol. 2011 Aug 10; 29(23):3153-62.
PMID:
21747089
.
Citations:
61
Fields:
Neo
Neoplasms
Translation:
Humans
Cells
Niedzwiecki D,
Bertagnolli MM
, Warren RS, Compton CC, Kemeny NE, Benson AB, Eckhardt SG, Alberts S, Porjosh GN, Kerr DJ, Fields A, Rougier P, Pipas JM, Schwartz JH, Atkins J, O'Rourke M, Perry MC, Goldberg RM,
Mayer RJ
, Colacchio TA. Documenting the natural history of patients with resected stage II adenocarcinoma of the colon after random assignment to adjuvant treatment with edrecolomab or observation: results from CALGB 9581. J Clin Oncol. 2011 Aug 10; 29(23):3146-52.
PMID:
21747085
.
Citations:
18